CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 108 enrolled
Drug / intervention
Misoprostol +1 moredrug
Likely dose
Misoprostol 50 mcg orally every 4 hours (up to 6 doses) OR Oxytocin 2 mU/min IV, increased by 2 mU/min every 15 minutes per hospital protocolAI-extracted
Key inclusion· 8
  • Rupture of membranes ≤24 hours prior with no evidence of labor
  • Gestational age at least 36 weeks
  • Nulliparous (no prior vaginal or cesarean delivery)
  • Singleton pregnancy in vertex (head-down) presentation
Key exclusion· 5
  • Prior cesarean section or other contraindication to vaginal delivery
  • Intrauterine fetal demise
  • Major congenital anomaly
  • Intraamniotic infection (chorioamnionitis) at time of admission

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04028765
NCT04028765Phase 4Completed

POM PROM: Pitocin or Oral Misoprostol for PROM IOL in Nulliparous Women With Unfavorable Cervical Exams

University of Pennsylvania·interventional·Posted Jul 23, 2019·Updated Apr 30, 2024

In Brief

A Phase 4 clinical trial evaluating Misoprostol and Oxytocin for PROM. Completed, enrolled 108 participants across 1 site.

Detailed Summary

Premature rupture of membranes (PROM) is a common occurrence of pregnancies at term. A delay from PROM to labor is associated with an increased risk of intrauterine infection and associated maternal and fetal morbidity; therefore, induction of labor (IOL) is recommended. The ideal agent for IOL is not known, particularly among specific subpopulations. The primary aim of this study is to determine if oxytocin (Pitocin) or oral misoprostol results in a shorter interval to delivery after the start of induction among nulliparous women with unfavorable cervical exams with term PROM.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPROM
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedJul 23, 2019
Enrollment StartAug 12, 2019
Primary CompletionDec 8, 2022
Study CompletionJan 8, 2023
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 6.9 years ago

Interventions

Misoprostoldrug

Oral misoprostol 50 mcg every 4 hours for up to 6 doses or until cervical ripening is no longer indicated

Oxytocindrug

IV Oxytocin 2 milliunits (mU)/min, increased by 2mU/min q15 minutes per hospital protocol